| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | -0.044 | 0.3 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | 0.17 | 0.3 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | 0.049 | 0.4 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.042 | 0.4 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | 0.036 | 0.4 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |